FDA Inspection 1231137 — The American National Red Cross Diagnostic Manufacturing Division

The American National Red Cross Diagnostic Manufacturing Division — FEI 1177732

The FDA completed an inspection of The American National Red Cross Diagnostic Manufacturing Division on February 13, 2024 in Gaithersburg, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 13, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Gaithersburg, MD (United States)